This is the 26th edition of This Weeks’ Biotech Highlights, which means Slaw has been hosting my ramblings for exactly half a year. Thanks! Other things I’m thankful for:
- Takeda Canada, which opened in Mississauga in March, got the ball rolling with their Canadian business by buying back rights to a diabetes drug from Eli Lilly.
- The National Research Counsel’s IRAP program, which received a tonne of Canadian stimulus money and has been making a lot of biotech investments lately.
- LOM and BioQuest, who created some excitement about Canada’s biotech industry by announcing a new joint